Prot# US OI 124: The PROTECT Study: A Prospective Observational Trial to Evaluate the Correlation of T-SPOT® Response to CMV Infection and T cell-mediated Acute Graft Rejection

Project: Research project

Project Details

StatusFinished
Effective start/end date7/14/167/15/19

Funding

  • Chiltern International, Inc. (Prot# US OI 124)
  • Oxford Immunotec, Inc. (Prot# US OI 124)